-
Something wrong with this record ?
Nonpharmacological intervention therapies for dementia: potential break-even intervention price and savings for selected risk factors in the European healthcare system
P. Maresova, L. Rezny, P. Bauer, M. Valko, K. Kuca
Language English Country England, Great Britain
Document type Journal Article
Grant support
ERDF No. CZ.02.1.01/0.0/0.0/18_069/0010054-IT4Neuro(degeneration)
Ministry of Education Youth and Sports
Excellence 2022
UHK FIM
NLK
BioMedCentral
from 2001-12-01
BioMedCentral Open Access
from 2001
Directory of Open Access Journals
from 2001
Free Medical Journals
from 2001
PubMed Central
from 2001
Europe PubMed Central
from 2001
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2001-01-01
Open Access Digital Library
from 2001-01-01
Medline Complete (EBSCOhost)
from 2001-01-01
Health & Medicine (ProQuest)
from 2009-01-01
Public Health Database (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
Springer Nature OA/Free Journals
from 2001-12-01
- MeSH
- Dementia * economics epidemiology prevention & control MeSH
- Middle Aged MeSH
- Humans MeSH
- Health Care Costs statistics & numerical data MeSH
- Prevalence MeSH
- Risk Factors MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Models, Theoretical MeSH
- Cost Savings MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Europe MeSH
BACKGROUND: New effective treatments for dementia are lacking, and early prevention focusing on risk factors of dementia is important. Non-pharmacological intervention therapies aimed at these factors may provide a valuable tool for reducing the incidence of dementia. This study focused on the development of a mathematical model to predict the number of individuals with neurodegenerative diseases, specifically Alzheimer's disease, Parkinson's disease, vascular dementia, and amyotrophic lateral sclerosis. Scenarios for non-pharmacological intervention therapies based on risk factor reduction were also assessed. The estimated total costs and potential cost savings from societal were included. METHODS: Based on demographic and financial data from the EU, a mathematical model was developed to predict the prevalence and resulting care costs of neurodegenerative diseases in the population. Each disease (Alzheimer's disease, Parkinson's disease, vascular dementia, and amyotrophic lateral sclerosis) used parameters that included prevalence, incidence, and death risk ratio, and the simulation is related to the age of the cohort and the disease stage. RESULTS: A replicable simulation for predicting the prevalence and resulting cost of care for neurodegenerative diseases in the population exhibited an increase in treatment costs from 267 billion EUR in 2021 to 528 billion EUR by 2050 in the EU alone. Scenarios related to the reduction of the prevalence of dementia by up to 20% per decade led to total discounted treatment cost savings of up to 558 billion EUR. CONCLUSION: The model indicates the magnitude of the financial burden placed on EU healthcare systems due to the growth in the population prevalence of neurodegenerative diseases in the coming decades. Lifestyle interventions based on reducing the most common risk factors could serve as a prevention strategy to reduce the incidence of dementia with substantial cost-savings potential. These findings could support the implementation of public health approaches throughout life to ultimately prevent premature mortality and promote a healthier and more active lifestyle in older individuals.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013948
- 003
- CZ-PrNML
- 005
- 20240905133919.0
- 007
- ta
- 008
- 240725s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12889-024-18773-7 $2 doi
- 035 __
- $a (PubMed)38741111
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Maresova, Petra $u Faculty of Informatics and Management, University of Hradec Kralove, Rokitanského 62, Hradec Kralove, 50003, Czech Republic
- 245 10
- $a Nonpharmacological intervention therapies for dementia: potential break-even intervention price and savings for selected risk factors in the European healthcare system / $c P. Maresova, L. Rezny, P. Bauer, M. Valko, K. Kuca
- 520 9_
- $a BACKGROUND: New effective treatments for dementia are lacking, and early prevention focusing on risk factors of dementia is important. Non-pharmacological intervention therapies aimed at these factors may provide a valuable tool for reducing the incidence of dementia. This study focused on the development of a mathematical model to predict the number of individuals with neurodegenerative diseases, specifically Alzheimer's disease, Parkinson's disease, vascular dementia, and amyotrophic lateral sclerosis. Scenarios for non-pharmacological intervention therapies based on risk factor reduction were also assessed. The estimated total costs and potential cost savings from societal were included. METHODS: Based on demographic and financial data from the EU, a mathematical model was developed to predict the prevalence and resulting care costs of neurodegenerative diseases in the population. Each disease (Alzheimer's disease, Parkinson's disease, vascular dementia, and amyotrophic lateral sclerosis) used parameters that included prevalence, incidence, and death risk ratio, and the simulation is related to the age of the cohort and the disease stage. RESULTS: A replicable simulation for predicting the prevalence and resulting cost of care for neurodegenerative diseases in the population exhibited an increase in treatment costs from 267 billion EUR in 2021 to 528 billion EUR by 2050 in the EU alone. Scenarios related to the reduction of the prevalence of dementia by up to 20% per decade led to total discounted treatment cost savings of up to 558 billion EUR. CONCLUSION: The model indicates the magnitude of the financial burden placed on EU healthcare systems due to the growth in the population prevalence of neurodegenerative diseases in the coming decades. Lifestyle interventions based on reducing the most common risk factors could serve as a prevention strategy to reduce the incidence of dementia with substantial cost-savings potential. These findings could support the implementation of public health approaches throughout life to ultimately prevent premature mortality and promote a healthier and more active lifestyle in older individuals.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a demence $x ekonomika $x epidemiologie $x prevence a kontrola $7 D003704
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a úspory nákladů $7 D017046
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a náklady na zdravotní péči $x statistika a číselné údaje $7 D017048
- 650 _2
- $a teoretické modely $7 D008962
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a lidé středního věku $7 D008875
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Rezny, Lukas $u Faculty of Informatics and Management, University of Hradec Kralove, Rokitanského 62, Hradec Kralove, 50003, Czech Republic
- 700 1_
- $a Bauer, Petr $u Faculty of Informatics and Management, University of Hradec Kralove, Rokitanského 62, Hradec Kralove, 50003, Czech Republic
- 700 1_
- $a Valko, Marian $u Slovak University of Technology, Bratislava, 81237, Slovakia
- 700 1_
- $a Kuca, Kamil $u Faculty of Informatics and Management, University of Hradec Kralove, Rokitanského 62, Hradec Kralove, 50003, Czech Republic. kamil.kuca@uhk.cz $u Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, 50005, Czech Republic. kamil.kuca@uhk.cz $u Andalusian Research Institute in Data Science and Computational Intelligence (DaSCI), University of Granada, Granada, 18071, Spain. kamil.kuca@uhk.cz
- 773 0_
- $w MED00008205 $t BMC public health $x 1471-2458 $g Roč. 24, č. 1 (2024), s. 1293
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38741111 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133913 $b ABA008
- 999 __
- $a ok $b bmc $g 2143637 $s 1225814
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 24 $c 1 $d 1293 $e 20240513 $i 1471-2458 $m BMC public health $n BMC Public Health $x MED00008205
- GRA __
- $a ERDF No. CZ.02.1.01/0.0/0.0/18_069/0010054-IT4Neuro(degeneration) $p Ministry of Education Youth and Sports
- GRA __
- $a Excellence 2022 $p UHK FIM
- LZP __
- $a Pubmed-20240725